admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Bullseye Chart: The Psychedelic Drug Development Pipeline

Israeli- Based Clearmind Medicine to Host Virtual Investor Conference on Psychedelics...

Opinions | Australia’s Rescheduling of MDMA and Psilocybin a Welcome First...

Panel: Neuroimaging in Psychedelic Research

PT387 – Psychedelic Ethics & Self-Reflexivity and Proposition 122 Conflict &...

Optimi Health Submits Phase I Clinical Trial Application Combining The Use...

PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New...

Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL

Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal...

Psychedelic Bulletin #130: Australia to Reschedule MDMA and Psilocybin; Small Pharma...

1...888990...218 Page 89 of 218

EDITOR PICKS

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin